AGA
NVRO

Altrinsic Global Advisors’s NEVRO CORP. NVRO Stock Holding History

Altrinsic Global Advisors’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-30,000
Closed -$1.88M – 84
2019
Q1 		$1.88M Sell
30,000
-5,000
-14% -$235K 0.09% 59
2018
Q4 		$1.36M Buy
+35,000
New +$1.56M 0.07% 64

Other funds holding NVRO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Altrinsic Global Advisors's NVRO Position: Q2 2019 in Review

Altrinsic Global Advisors sold out of NEVRO CORP. (NVRO) in Q2 2019, closing a stake of 30,000 shares — an estimated $1.88M sold.

Altrinsic Global Advisors first reported a position in NVRO in Q4 2018 and held it in 2 quarters. The position peaked at $1.88M in Q1 2019. 162 funds tracked by Wall St. Rank hold NVRO as of Q2 2019.

  • Altrinsic Global Advisors reported no remaining NEVRO CORP. position as of Q2 2019 after selling out during the quarter.
  • Altrinsic Global Advisors sold 30,000 NEVRO CORP. shares in Q2 2019, an estimated $1.88M.
  • Altrinsic Global Advisors first reported a position in NEVRO CORP. in Q4 2018 and held it in 2 quarters.
  • Altrinsic Global Advisors's NEVRO CORP. position peaked at $1.88M in Q1 2019.
  • 162 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2019.

Based on Altrinsic Global Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.